Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics, Inc. (SPTX)
For the quarter ending 2026-03-31, SPTX has $227,673K in assets. $17,966K in debts. $52,909K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 52,909 | |||
| Short-term investments | 129,696 | |||
| Prepaid expenses and other current assets | 5,736 | |||
| Total current assets | 188,341 | |||
| Property and equipment | 1,401 | |||
| Less accumulated depreciation | 1,015 | |||
| Property and equipment, net | 386 | |||
| Right-of-use assets - operating leases | 5,066 | |||
| Long-term investments | 30,037 | |||
| Other non-current assets | 3,843 | |||
| Total assets | 227,673 | |||
| Accounts payable | 4,787 | |||
| Related party payable | 11 | |||
| Accrued expenses and other current liabilities | 7,826 | |||
| Operating lease liability | 1,599 | |||
| Total current liabilities | 14,223 | |||
| Operating lease liability, net of current portion | 3,743 | |||
| Total liabilities | 17,966 | |||
| Convertible preferred stock-Series A-1Convertible Preferred Stock | 0 | |||
| Convertible preferred stock-Series A-2Convertible Preferred Stock | 99,757 | |||
| Convertible preferred stock-Series BConvertible Preferred Stock | 225,571 | |||
| Common stock, par value 0.0001 159,070,000 shares authorized 2,595,342 and 2,594,960 shares issued and outstanding as of march 31, 2026 and december 31, 2025 respectively | 1 | |||
| Cumulative translation adjustment | 0 | |||
| Additional paid-in capital | 23,831 | |||
| Accumulated other comprehensive income | 64 | |||
| Accumulated deficit | -139,517 | |||
| Total stockholders' deficit | -115,621 | |||
| Total liabilities, convertible preferred stock and stockholders' deficit | 227,673 | |||